期刊文献+

耐甲氧西林金黄葡萄球菌小鼠菌血症感染模型的建立与评估 被引量:4

Establishment and evaluation of a bacteriemia model in mice after infection with an isolated methicillin-resistant Staphylococcus aureus( MRSA )
原文传递
导出
摘要 目的 本研究采用临床分离鉴定的ST-239型耐甲氧西林金黄葡萄球菌(MRSA)感染BALB/c小鼠,建立菌血症感染模型.方法 从小鼠的临床症状、生存曲线和主要组织器官的病理学变化进行了时相性监测,并用该模型验证万古霉素对小鼠菌血症的治疗效果.结果 ST-239型MRSA感染的小鼠血液中细菌含量较高,小鼠炎症反应严重并伴有心、肺等多组织器官的损伤;对小鼠使用万古霉素后可显著降低血液中的细菌量,动物存活率明显提高,主要组织器官的病理学症状减轻.结论 该模型的建立将为进一步研究临床分离的MRSA的病原特性、发病机制、治疗方法等提供可靠的实验动物模型. Objective To established a bacteriemia model of BALB/c mice after infection with a ST-239 methicillin-resistant staphylococcus aureus(MRSA) strain, which was isolated and identified from Shanghai Huashan Hospital. Methods We monitored the clinical signs and gross observations of MRSA-infected mice, and examined the histopathology among different groups. Results This isolated MRSA strain ST-239 can induced a typical bacteriemia in BALB/c mice, including the severe mortality and extensive histopathologic injury. However, higher survival rate and slight inflammatory injury were observed in vancomycin-treated mices. Conclusion The solid results obatined in this model will benefit us to study the pathogenic characteristics and patholgenesis in MRSA-induced bacteriemia, and propeled us to seek a safety cure approaches in the future.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2010年第7期603-607,共5页 Chinese Journal of Microbiology and Immunology
基金 基金项目:上海市科委资助项目(07DZ19503)
关键词 耐甲氧西林金黄葡萄球菌 菌血症 小鼠模型 Methicillin-resistant staphylococcus aureus(MRSA) Bacteriemia Mice model
  • 相关文献

参考文献26

  • 1Grundmann H,Aires-de-Sousa M,Boyce J,et al.Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a publichealth threat.Lancet,2006,368(9538):874-885.
  • 2Daum RS,Seal JB.Evolving antimicrobial chemotherapy for Staphylococcus aureus infections:Our backs to the wall.Crit Care Med,2001,29(4 Suppl):N92-96.
  • 3Maltezou HC,Giamarellou H.Community-acquired methicillin-resistant Staphylococcus aureus infections.Int J Antimicrob Agents,2006,27(2):87-96.
  • 4Otter JA,French GL.Nosocomial transmission of community-associated methicillin-resistant Staphylococcus aureus:an emerging threat.Lancet Infect Dis,2006,6(12):753-755.
  • 5Goldstein EJ,Citron DM,Warren YA,et al.Virulence characteristics of community-associated Staphylococcus aureus and in vitro activities of moxifloxacin alone and in combination against community-associated and healthcare-associated meticillin-resistant and susceptible S.aureus.J Med Microbiol,2008,57 (Pt 4):452-456.
  • 6Adedeji A,Gray JW.MRSA at an English children's hospital from 1998 to 2003.Arch Dis Child,2005,90(7):720-723.
  • 7Faria NA,Oliveira DC,Westh H,et al.Epidemiology of emerging methicillin-resistant Staphylococcus aureus (MRSA) in Denmark:a nationwide study in a country with low prevalence of MRSA infection.J Clin Microbiol,2005,43(4):1836-1842.
  • 8Haddadin AS,Fappiano SA,Lipsett PA.Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit.Postgrad Med J,2002,78(921):385-392.
  • 9Sax H,Harbarth S,Gavazzi G,et al.Prevalence and prediction of previously unknown MRSA carriage on admission to a geriatric hospital.Age Ageing,2005,34(5):456-462.
  • 10Smith NP,Nelson MR,Azadian B,et al.An outbreak of methicillin-resistant Staphylococcus aureus (MRSA) infection in HIVseropositive persons.Int J STD AIDS,1998,9(12):726-730.

二级参考文献26

  • 1李红玉,李国成,潘昆贻,伍锡泉,钟日辉.2000-2003年广州地区耐甲氧西林金黄色葡萄球菌耐药变迁及治疗对策[J].广东药学,2005,15(6):31-33. 被引量:8
  • 2李景云,马越,张力,胡昌勤,金少鸿.临床52家医院常见分离菌株的药物敏感性监测[J].中华检验医学杂志,2006,29(5):452-457. 被引量:92
  • 3Ko K S,Lee J Y,Suh JY,et al.Distribution of major genotypes among methicillin-resistant Staphylococcus aureus clones in Asian countries[J].J Clin Microbiol,2005,43:421-426.
  • 4Kerttula AM,Lyytikainen O,Karden L M,et al.Nationwide trendsin molecular epidemiology of methicillin-resistant Staphylococcus aureus.Finland,1997~2004[J].BMC Infect Dis,2007,7:94.
  • 5Huang YC,Chen PY,Hwang KP,et al.Prevalence of methicillin-resistant Staphylococcus aureus nasal colonization among Taiwan Residents children in 2005 and 2006[J].J Clin Microbiol,2007,45(12):3992-3995.
  • 6Enright M C,Robinson D A,Randle G,et al.The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)[J].Proc Natl Acad Sci USA,2002,99(11):7687-7692.
  • 7Oliveira DC,Tomasz A,de Lencastre H.The evolution of pandemic clones of methicillin-resistant Staphylococcus aureus:identification of two ancestral genetic backgrounds and the associated mec elements[J].Microb Drug Resist,2001,7(4):349-361.
  • 8Oliveira D C,Tomasz A,de Lencastre H.Secrets of success of a human pathogen:molecular evolution of pandemic clones of meticillin resistant Staphylococcus aureus[J].Lancet Infect Dis,2002,2(3):180-189.
  • 9Robinson D A,Mark C Enright.Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus[J].Antimicrob Agents Chemother,2003,47:3926-3934.
  • 10Robinson DA,Enright M C.Multilocus 1 seque-nce typing and the evolution of methicillin-resistant Staphylococcus aureus[J].Clin Microbiol Infect,2004,10:92-97.

共引文献95

同被引文献31

  • 1Nickerson EK,West TE,Day NP,et al,Staphylococcus augus disease and drug resistance in resource-limited countries in south and east Asia[J].Lancet Infect Dis,2009,9(2):130-135.
  • 2CDC.Staphylococcus aureus resistant to vancomycin--United States[J].J Am Med Assoc,2002,288 (7):824-825.
  • 3Kokai-Kun JF,Chanturiva T Mond JJ.Lysostaphin as a treatment for systemic Staphyloccus aureus infection in a mouse model[J].J Antimicrob Chemother,2007,60(5):1051-1059.
  • 4Brakstad OG,Aasbakk K,Maeland JA.Detec/ion of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene[J].J Clin Microbiol,1992,30(7):1654-1660.
  • 5Lim TT,Coombs GW,Grubb WB.Genetic organization of mecA and mecA-regulatory genes in epidemic methicillin-resistant Staphylococcus aureus from Australia and England[J].J A nlimicrob Chemother,2002,50(6):819-824,.
  • 6Louie L,Matsumura SO,Choi E,et al.Evaluation of three rapid methods for detection of methicillin resistance in Staphylococcus aureus[J].J Clin Microbiol,2000,38(6):2170-2173.
  • 7Rodvold KA,Nicolau DP,Lodise TP,et al.Identifying exposure targets for treatment of Staphylococcal pneumonia with ceftobiprole[J].Antimicrob Agents Chemother,2009,53 (8):3294-3301,.
  • 8Wolkewitz M,Frank U,Philips G,et al.Mortality associated with in-hospital bacteraemia caused by Staphylocccus aureus:a multistate analysis with follow-up beyond hospital discharge[J].J Antimicrob Chemother,2011,66 (2):381-386.
  • 9Hidayat LK,Hsu D,Quist R,et al.High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections:efficacy and toxicity[J].Arch Intern Med,2006,166(19):2138-2144.
  • 10Paul M,Kariv G,Goldberg E,et al.Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia[J].J Antimicrob Chemother,2010,65(12):2658-2665.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部